The Industry Standard: Intelligence for the Information Economy

  September 5, 2001
  NEWS & ANALYSIS
   Headlines
   Money & Markets
   Tech & Telecom
   Media & Marketing
   Metrics & Stats
   Policy & Politics
  SEARCH
   
  advanced search
  SERVICES
   Company Index
   Newsletters
   Wireless
  PRINT EDITION
   Read the Magazine

Home > Company Index > Drugs > Biotechnology-Medicine > Viragen, Inc.

Viragen, Inc.
AMEX: VRA
Change
symbol:
     
 PROFILE
Viragen is no buttinsky. The development-stage company works with human interferons, which it hopes to use to treat cancer (particularly melanoma), AIDS, hepatitis B and C, and multiple sclerosis. Produced in white blood cells, interferons interfere with the growth of malignant cancer cells and such foreign substances as viruses. Viragen has developed but not yet received FDA or European Union approval for Omniferon, an injectable form of human interferon. The company has white blood cell supply agreements with The American Red Cross, America's Blood Centers, the Scottish National Blood Transfusion Service, and German Red Cross blood blanks. Viragen conducts the majority of its research in Scotland.

 COMPETITION
Genentech, Inc. (DNA)
GlaxoSmithKline plc (GSK)
Schering-Plough Corporation (SGP)

 STOCK ANALYSIS
 View by:
 Day 
 Day 
 Month 
 Month 
 Year 
 Year 
FURTHER ANALYSIS
• Advanced Charting
• Deals

 FINANCIAL OVERVIEW
Fiscal Year-End: June
2000 Sales (mil.): 0.10
1-Yr. Sales Growth: (75.0)%
Employees: 42
Revenue per employee: $2,380.95

 KEY PEOPLE
• Gerald Smith
    CEO
• Dennis W. Healey
    CFO

 CONTACT INFO
865 SW 78th Ave., Ste. 100
Plantation, FL 33324
US
Phone: 954-233-8746
Fax: 954-233-1414
Online: Web Site

Company Data   News, quotes & more       

Hoovers Online   Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.


ADVERTISEMENT
FEATURED LINKS
Home |  Customer Service |  About Us
Australia |  Brazil |  China |  Korea |  Norway |  Poland |  Sweden |  Taiwan

Copyright ©2001 Standard Media International. Privacy Policy
Stock data provided by Stockpoint and its data suppliers. Copyright © 1995-2001